Zdrowie i gospodarka · 13/06/2025

FDA Classifies Device to Detect Fungal Nucleic Acids in Respiratory Specimens into Class II Special Controls

The FDA is classifying a device that detects and identifies fungal nucleic acids directly in respiratory specimens into Class II special controls, aiming to enhance patient access to innovative devices while ensuring safety and effectiveness.